PURPOSE: The vesicular acetylcholine transporter (VAChT) is a specific biomarker for imaging presynaptic cholinergic neurons. The syntheses and C-11 labeling of two potent enantiopure VAChT inhibitors are reported here. PROCEDURES: Two VAChT inhibitors, (±)-2 and (±)-6, were successfully synthesized. A chiral HPLC column was used to resolve the enantiomers from each corresponding racemic mixture for in vitro characterization. The radiosyntheses of (-)-[(11)C]2 and (-)-[(11)C]6 from the corresponding desmethyl phenol precursor was accomplished using [(11)C]methyl iodide or [(11)C]methyl triflate, respectively. RESULTS: The synthesis of (-)-[(11)C]2 was accomplished with 40-50 % radiochemical yield (decay-corrected), SA > 480 GBq/μmol (EOB), and radiochemical purity >99 %. Synthesis of (-)-[(11)C]6 was accomplished with 5-10 % yield, SA > 140 GBq/μmol (EOB), and radiochemical purity >97 %. The radiosynthesis and dose formulation of each tracer was completed in 55-60 min. CONCLUSIONS: Two potent enantiopure VAChT ligands were synthesized and (11)C-labeled with good radiochemical yield and specific activity.
PURPOSE: The n class="Gene">vesicular acetylcholine transporter (VAChT) is a specific biomarker for imaging presynaptic cholinergic neurons. The syntheses and C-11 labeling of two potent enantiopure VAChT inhibitors are reported here. PROCEDURES: Two VAChT inhibitors, (±)-2 and (±)-6, were successfully synthesized. A chiral HPLC column was used to resolve the enantiomers from each corresponding racemic mixture for in vitro characterization. The radiosyntheses of (-)-[(11)C]2 and (-)-[(11)C]6 from the corresponding desmethyl phenol precursor was accomplished using [(11)C]methyl iodide or [(11)C]methyl triflate, respectively. RESULTS: The synthesis of (-)-[(11)C]2 was accomplished with 40-50 % radiochemical yield (decay-corrected), SA > 480 GBq/μmol (EOB), and radiochemical purity >99 %. Synthesis of (-)-[(11)C]6 was accomplished with 5-10 % yield, SA > 140 GBq/μmol (EOB), and radiochemical purity >97 %. The radiosynthesis and dose formulation of each tracer was completed in 55-60 min. CONCLUSIONS: Two potent enantiopure VAChT ligands were synthesized and (11)C-labeled with good radiochemical yield and specific activity.
Authors: Nicolas Giboureau; Ian Mat Som; Aurélie Boucher-Arnold; Denis Guilloteau; Michael Kassiou Journal: Curr Top Med Chem Date: 2010 Impact factor: 3.295
Authors: Junfeng Li; Xiang Zhang; Zhanbin Zhang; Prashanth K Padakanti; Hongjun Jin; Jinquan Cui; Aixiao Li; Dexing Zeng; Nigam P Rath; Hubert Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu Journal: J Med Chem Date: 2013-07-18 Impact factor: 7.446
Authors: Wei Wang; Jinquan Cui; Xiaoxia Lu; Prashanth K Padakanti; Jinbin Xu; Stanley M Parsons; Robert R Luedtke; Nigam P Rath; Zhude Tu Journal: J Med Chem Date: 2011-07-20 Impact factor: 7.446
Authors: Simon M N Efange; Anil B Khare; Krystyna von Hohenberg; Robert H Mach; Stanley M Parsons; Zhude Tu Journal: J Med Chem Date: 2010-04-08 Impact factor: 7.446
Authors: Vania F Prado; Cristina Martins-Silva; Braulio M de Castro; Ricardo F Lima; Daniela M Barros; Ernani Amaral; Amy J Ramsey; Tatyana D Sotnikova; Maria R Ramirez; Hyung-Gun Kim; Janine I Rossato; Janaina Koenen; Hui Quan; Vinicius R Cota; Marcio F D Moraes; Marcus V Gomez; Cristina Guatimosim; William C Wetsel; Christopher Kushmerick; Grace S Pereira; Raul R Gainetdinov; Ivan Izquierdo; Marc G Caron; Marco A M Prado Journal: Neuron Date: 2006-09-07 Impact factor: 17.173
Authors: Zhude Tu; Simon M N Efange; Jinbin Xu; Shihong Li; Lynne A Jones; Stanley M Parsons; Robert H Mach Journal: J Med Chem Date: 2009-03-12 Impact factor: 7.446
Authors: J Mazère; C Prunier; O Barret; M Guyot; C Hommet; D Guilloteau; J F Dartigues; S Auriacombe; C Fabrigoule; M Allard Journal: Neuroimage Date: 2007-12-03 Impact factor: 6.556
Authors: Michael R Kilbourn; Brian Hockley; Lihsueh Lee; Phillip Sherman; Carole Quesada; Kirk A Frey; Robert A Koeppe Journal: Nucl Med Biol Date: 2009-05-08 Impact factor: 2.408
Authors: Hongjun Jin; Xiang Zhang; Xuyi Yue; Hui Liu; Junfeng Li; Hao Yang; Hubert Flores; Yi Su; Stanley M Parsons; Joel S Perlmutter; Zhude Tu Journal: Nucl Med Biol Date: 2015-11-07 Impact factor: 2.408
Authors: Xuyi Yue; Hongjun Jin; Hui Liu; Zonghua Luo; Xiang Zhang; Kota Kaneshige; Hubert P Flores; Joel S Perlmutter; Stanley M Parsons; Zhude Tu Journal: Org Biomol Chem Date: 2017-06-21 Impact factor: 3.876
Authors: Prashanth K Padakanti; Xiang Zhang; Hongjun Jin; Jinquan Cui; Ruike Wang; Junfeng Li; Hubert P Flores; Stanley M Parsons; Joel S Perlmutter; Zhude Tu Journal: Mol Imaging Biol Date: 2014-12 Impact factor: 3.488
Authors: Zhude Tu; Xiang Zhang; Hongjun Jin; Xuyi Yue; Prashanth K Padakanti; Lihai Yu; Hui Liu; Hubert P Flores; Kota Kaneshige; Stanley M Parsons; Joel S Perlmutter Journal: Bioorg Med Chem Date: 2015-06-05 Impact factor: 3.641
Authors: Xuyi Yue; Zonghua Luo; Hui Liu; Kota Kaneshige; Stanley M Parsons; Joel S Perlmutter; Zhude Tu Journal: Bioorg Med Chem Lett Date: 2018-09-24 Impact factor: 2.823